BridgeMD
New treatment option for Adolescence Idiopathic Scoliosis
Official title Machine Learning Prediction of Disease Progression in Adolescent Idiopathic Scoliosis
ClinicalTrials.gov ID: NCT07556042
What this study is testing
- What it's testing
- Background and Problem Overview Adolescent Idiopathic Scoliosis (AIS) is a progressive musculoskeletal disorder characterized by a three-dimensional deformation of the spine occurring during adolescence. Diagnosis is typically established with a Cobb angle exceeding 10° and the presence of axial rotation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 18
You may be able to join if
- being between the ages of 10 and 18
- having a Cobb angle between 10 and 40 degrees
- not receiving any other exercise treatment (scoliosis-specific exercises, etc.) from a different center that would affect the patient's scoliosis
You likely can't join if
- history of scoliosis surgery
- patients who had undergone any type of surgical procedure within the last 3 months were excluded
- orthopedic, neurological, or systemic diseases that would hinder exercise
- Intellectual, behavioral, or communication disorders affecting understanding of instructions or exercise performance, or participation in any exercise
The study team makes the final eligibility decision.
Where it's taking place
- Istanbul, Eyupsultan, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Istanbul, Eyupsultan, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.